Rani Therapeutics Holdings, Inc.
Recent Filings
All 342 filings →| Form | Description | Date |
|---|---|---|
| 3 | — | Mar 27, 2026 |
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| S-8 | S-8 | Mar 26, 2026 |
| 10-K | 10-K | Mar 26, 2026 |
| 8-K | 8-K | Mar 26, 2026 |
| SCHEDULE 13G | — | Feb 13, 2026 |
| SCHEDULE 13G | — | Feb 12, 2026 |
| SCHEDULE 13G | — | Jan 30, 2026 |
| 8-K | 8-K | Jan 2, 2026 |
| DEF 14C | DEF 14C | Dec 5, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| IMRAN MIR A | — | Purchase | 2,083,334 @ $0.61 | 2,083,334 | Oct 23, 2025 |
| South Cone Investments Limited Partnership | — | Sale | 1,923,000 @ $2.41 | 6,379,194 | Oct 21, 2025 |
| McKinley Kate | Chief Business Officer | Purchase | 17,960 @ $1.67 | 17,960 | Dec 13, 2024 |
| Imran Talat | Chief Executive Officer | Purchase | 10,296 @ $1.94 | 494,751 | Dec 9, 2024 |
| South Cone Investments Limited Partnership | — | Sale | 523,738 @ $3.26 | 8,302,194 | Oct 15, 2024 |
| Imran Talat | Chief Executive Officer | Purchase | 10,000 @ $2.27 | 484,455 | Dec 6, 2023 |
| Imran Talat | Chief Executive Officer | Purchase | 5,000 @ $2.57 | 474,455 | Dec 4, 2023 |
| Imran Talat | Chief Executive Officer | Purchase | 20,000 @ $2.05 | 469,455 | Nov 29, 2023 |
| Aequanimitas Limited Partnership | — | Sale | 5,265,165 @ $2.01 | 8,400 | Nov 24, 2023 |
| South Cone Investments Limited Partnership | — | Purchase | 5,265,165 @ $2.01 | 12,131,554 | Nov 24, 2023 |